Outcome, Fatal, SARS-CoV-2
Conditions
Brief summary
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of international concern. Despite lower mortality rate, SARS-CoV-2 has killed more people than SARS and MERS and the number keeps growing. Epidemic studies have been well described clinical features of patients with COVID-19, with the disease severity being an independent predictor of poor outcome. However, there is still no research investigating the prognostic factors of patients with COVID-19.
Interventions
None listed
Sponsors
Chongqing Medical University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult aged \>=18years old; * Diagnosed with CONVID19. Diagnostic criteria including: Laboratory (RT-PCR) confirmed SARS-Cov-2 infection; CT of the lung conformed to the manifestation of viral pneumonia. * Criteria for severe or critical ill conditions: Respiratory rate \>=30/min; or Rest SPO2\<=93%; or PaO2/FiO2\<=300mmHg.
Exclusion criteria
* Near-death state (expected survival time less than 24 hours); * Malignant tumor; * Pregnancy or puerperium women; * Patients who refused to participant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| all-cause mortality | 30 days |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| all-cause mortality | 15 days | — |
| Severe state | 15 days | Criteria for severe or critical ill conditions: Respiratory rate \>=30/min; or Rest SPO2\<=93%; or PaO2/FiO2\<=300mmHg. |
Countries
China
Outcome results
None listed